Latest News for GRFS
Diversify Wealth Management LLC bought a new position in Grifols, S.A. (NASDAQ: GRFS) during the undefined quarter, according to its most recent filing with the SEC. The institutional investor bought 122,588 shares of the biotechnology company's stock, valued at approximately $1,156,000. A number of other hedge funds have also recently made changes to
Grifols, S.A. (GIKLY) Q4 2025 Earnings Call Transcript
Spanish drugmaker Grifols reported on Thursday a net profit of 402 million euros ($473.96 million) for 2025, more than double what it recorded the previous year, driven by revenues of 7.5 billion euros, up 7% from a year earlier.
Grifols (NASDAQ: GRFS - Get Free Report) is projected to issue its Q4 2025 results before the market opens on Wednesday, February 25th. Analysts expect the company to announce earnings of $0.29 per share and revenue of $1.9551 billion for the quarter. Investors may review the information on the company's upcoming Q4 2025 earning report for
Insightful Analysis of Brandes Investment Partners, LP (Trades, Portfolio)'s Fourth Quarter 2025 13F Filing Brandes Investment Partners, LP (Trades, Portfolio)
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for GRFS.
Senate Trading
No Senate trades found for GRFS.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.